Ollin nets $330M to fund Phase 3 trials of Vabysmo challenger from China (OLN324) on June 24, 2026 China Innovent Biologics Macular edema due to diabetes mellitus Ollin OLN324 Phase 3 Series B Vabysmo wet AMD +
Roche in Talks With US on Drug Pricing; Sets Out Pipeline and Dealmaking Ambitions on October 23, 2025 Benefit dealmaking direct-to-consumer sales drug price gene therapy government Hemlibra Investments manager manufacturing Ocrevus Pharmaceutical Services pipeline R&D Roche (company) U.S. Vabysmo +
Ollin Biosciences Launches with $100M to Challenge Roche in Eye Disease Market on September 17, 2025 Ang2 Biosciences Clinical Trials Disorder of eye Macular edema due to diabetes mellitus Ollin OLN324 Roche (company) Vabysmo Vascular Endothelial Growth Factor A Wet AMD +
Roche Pledges Nearly $300M to Establish New Vabysmo Production Plant in China on May 13, 2025 biopharmaceutical manufacturing China Disorder of eye green energy Investments localization plant construction Roche (company) Shanghai Vabysmo +